Literature DB >> 12029431

When the treatment goal is not cure: are patients informed adequately?

Martin H N Tattersall1, Melina Gattellari, Katie Voigt, Phyllis N Butow.   

Abstract

We determined the extent to which Australian patients with incurable cancer are informed of their prognosis and treatment options by their oncologists and are encouraged to participate in treatment decisions. To this end, 118 patients with incurable cancer presenting for an initial consultation with one of nine oncologists in two Sydney teaching hospitals were enrolled in the study. Consultations were audio-taped. We developed a coding system to assess the disclosure of information considered necessary to equip patients to make informed decisions and to evaluate doctor encouragement of patient participation in treatment decision-making. Patient recall, satisfaction, and anxiety and their perceptions of the decision-making process were assessed. Most patients were informed about the aim of cancer treatment (84.7%), that their disease was incurable (74.6%) and about life expectancy (57.6%); 44.1% were presented with an alternative to cancer treatments, such as supportive care, 36.3% were informed how anticancer treatment would affect quality of life, and 29.7% were offered a management choice. Patient understanding was checked in only 10% of consultations. While greater information disclosure did not appear to elevate anxiety levels, greater patient participation in the decision making process was associated with increased anxiety levels ( P=0.0005), which persisted over a 2-week time span. Most patients were well informed, but important gaps remain, especially concerning information about prognosis and alternatives to cancer treatment.

Entities:  

Keywords:  Death and Euthanasia; Empirical Approach; Professional Patient Relationship

Mesh:

Year:  2001        PMID: 12029431     DOI: 10.1007/s005200100291

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  18 in total

1.  Patients' understanding of clinical trials needs to be assessed in the context of understanding of overall goals of care.

Authors:  Jaclyn Yoong; Michael Jefford; Linda Mileshkin
Journal:  Support Care Cancer       Date:  2011-06-03       Impact factor: 3.603

2.  Studying physician-patient communication in the acute care setting: the hospitalist rapport study.

Authors:  Wendy G Anderson; Kathryn Winters; Robert M Arnold; Kathleen A Puntillo; Douglas B White; Andrew D Auerbach
Journal:  Patient Educ Couns       Date:  2010-05-04

Review 3.  Sedation in clinical oncology.

Authors:  Manuel González Barón; César Gómez Raposo; Alvaro Pinto Marín
Journal:  Clin Transl Oncol       Date:  2005-08       Impact factor: 3.405

4.  Shared decision making in oncology: assessing oncologist behaviour in consultations in which adjuvant therapy is considered after primary surgical treatment.

Authors:  Simron Singh; Phyllis Butow; Margaret Charles; Martin H N Tattersall
Journal:  Health Expect       Date:  2010-06-23       Impact factor: 3.377

Review 5.  Recommendations for enhancing clinical trials education: a review of the literature.

Authors:  Karen A Stepan; Amy P Gonzalez; Vivian S Dorsey; Debra K Frye; Nita D Pyle; Regina F Smith; Terry A Throckmorton; Louise A Villejo; Scott B Cantor
Journal:  J Cancer Educ       Date:  2011-03       Impact factor: 2.037

6.  Dancing around death: hospitalist-patient communication about serious illness.

Authors:  Wendy G Anderson; Susan Kools; Audrey Lyndon
Journal:  Qual Health Res       Date:  2012-10-03

7.  Disclosure preferences regarding cancer diagnosis and prognosis: to tell or not to tell?

Authors:  H Miyata; M Takahashi; T Saito; H Tachimori; I Kai
Journal:  J Med Ethics       Date:  2005-08       Impact factor: 2.903

Review 8.  [On disclosing a diagnosis of dementia].

Authors:  G Lämmler; E Stechl; E Steinhagen-Thiessen
Journal:  Z Gerontol Geriatr       Date:  2007-04       Impact factor: 1.281

Review 9.  Effective communication about the use of complementary and integrative medicine in cancer care.

Authors:  Moshe Frenkel; Lorenzo Cohen
Journal:  J Altern Complement Med       Date:  2013-07-17       Impact factor: 2.579

Review 10.  Communication about cancer near the end of life.

Authors:  Anthony L Back; Wendy G Anderson; Lynn Bunch; Lisa A Marr; James A Wallace; Holly B Yang; Robert M Arnold
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.